The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Tralieve 20 mg chewable tablets for dogs

20 mg/tablet Chewable tablet

Le Vet Beheer B.V.VPA10475/036/001

Main Information

Trade NameTralieve 20 mg chewable tablets for dogs
Active SubstancesTramadol hydrochloride
Strength20 mg/tablet
Dosage FormChewable tablet
Licence HolderLe Vet Beheer B.V.
Licence NumberVPA10475/036/001

Group Information

ATC CodeQN02AX02 tramadol
Therapeutic ClassAnaesthetic/Analgesic


Licence Issued06/07/2018
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back